Strs Ohio Syros Pharmaceuticals, Inc. Transaction History

Strs Ohio

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 Apr 20, 2018	SELL	$9.47 - $12.98 $14,205 - $19,470	-1,500 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$13.52 - $23.75 $20,280 - $35,625	1,500	1,500 $22,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.